🕵️ Cbdmd, Inc. ($YCBD)
SEC insider & ownership activity, last 12 months · CIK 1644903 · every row links its SEC filing
Over the last 12 months insiders sold $1.3M with no open-market buying against it. Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust Dated April 4, 2018, AMC Legacy Trust Dated December 21, 2012 sold $1.3M in discretionary trades (Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $1.3M (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust Dated April 4, 2018, AMC Legacy Trust Dated December 21, 2012 | 0 | – | 3 | $1.3M | Dec 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| CRC Investment Fund LP ("CRC LP") | 9.2% | 13G | May 12, 2025 | filing ↗ | |
| Jeffrey H. Porter | 6.4% | 13D | May 6, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust Dated April 4, 2018, AMC Legacy Trust Dated December 21, 2012 | $2.2M | Dec 17, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | May 20, 2026 | filing ↗ |
| New financial obligation (2.03) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Other events (8.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Earnings (2.02) | Nov 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 21, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 30, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 30, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |